Human Metapneumovirus-associated Hospital Burden in Older Adults in Scotland: A Retrospective Analysis
Durga Kulkarni1, Richard Osei-Yeboah1, Kate Templeton2
1Centre for Global Health, Usher Institute, University of Edinburgh, Edinburgh, UK.
Background:
Human metapneumovirus (hMPV) is commonly associated with respiratory tract infections (RTIs) in older adults.
Method:
We estimated the annual hospital incidence of hMPV RTIs in older adults in Scotland over 6 seasons (2017-2023) using national hospital and laboratory data. Hospital incidence in Scottish health boards other than Lothian, where testing practices were uncertain, was extrapolated using Lothian's comprehensive laboratory data. We also assessed the severity and mortality outcomes of laboratory-confirmed hMPV episodes in older adults in Scotland. Additionally, we developed similar estimates for respiratory syncytial virus (RSV) and Influenza A for comparisons.
Results:
This analysis included 626 laboratory-confirmed hMPV hospitalizations. Only 28% of laboratory-confirmed hMPV episodes were clinically coded. The extrapolated hMPV hospital incidence ranged from 3.6/100 000 to 49.5/100 000 in adults aged ≥60 y in Scotland, and the extrapolated incidence was 1.3 to 3.8 times higher than the incidence of laboratory-confirmed data. The hospital incidence was higher in ≥75 y than in 60-74 y. hMPV incidence dropped substantially during the COVID-19 pandemic. The case fatality rates were higher in the ≥75 y compared with the 60-74 y, but ICU admissions were more common in the 60-74 y. The hospital incidence of RSV and Influenza A seemed higher than hMPV, but the 95% confidence intervals for severity and outcomes generally overlapped.
Conclusions:
hMPV RTIs pose a substantial hospital burden in older adults in Scotland. The differences between laboratory-confirmed and extrapolated estimates highlight the need for improved surveillance, diagnosis, and coding practices to develop robust burden estimates. The clinical severity of hMPV could be similar to RSV.
Related Concept Videos
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:30Pneumonia III: Complications and Assessment
01:29Pneumonia II: Pathophysiology
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:25Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...